Elevated membrane-type matrix metalloproteinases in gliomas revealed by profiling proteases and inhibitors in human cancer cells.
about
Development of a novel tumor-targeted vascular disrupting agent activated by membrane-type matrix metalloproteinasesMMP25 (MT6-MMP) is highly expressed in human colon cancer, promotes tumor growth, and exhibits unique biochemical propertiesHistone deacetylase inhibitors modulate metalloproteinase gene expression in chondrocytes and block cartilage resorptionCyclical strain modulates metalloprotease and matrix gene expression in human tenocytes via activation of TGFβComprehensive profiling and localisation of the matrix metalloproteinases in urothelial carcinoma.Matrix metalloproteinase 13 is induced in fibroblasts in polyomavirus middle T antigen-driven mammary carcinoma without influencing tumor progression.Gamma-secretase represents a therapeutic target for the treatment of invasive glioma mediated by the p75 neurotrophin receptorComparative expression pattern of Matrix-Metalloproteinases in human glioblastoma cell-lines and primary cultures.Expression of matrix metalloproteinases 2 and 9 in human gastric cancer and superficial gastritis.Dietary garlic and hip osteoarthritis: evidence of a protective effect and putative mechanism of actionProtease-Inhibitor Interaction Predictions: Lessons on the Complexity of Protein-Protein InteractionsMembrane-type 4 matrix metalloproteinase (MT4-MMP) modulates water homeostasis in mice.Antimycobacterial drugs modulate immunopathogenic matrix metalloproteinases in a cellular model of pulmonary tuberculosis.ADAM and ADAMTS gene expression in native and wound healing human lens epithelial cellsERK5 signalling in prostate cancer promotes an invasive phenotype.Metzincin proteases and their inhibitors: foes or friends in nervous system physiology?Evaluating Osteoarthritic Chondrocytes through a Novel 3-Dimensional In Vitro System for Cartilage Tissue Engineering and Regeneration.Modulation of microRNA editing, expression and processing by ADAR2 deaminase in glioblastoma.Proteolysis of the matricellular protein hevin by matrix metalloproteinase-3 produces a SPARC-like fragment (SLF) associated with neovasculature in a murine glioma model.Expression profiling of metalloproteinases and their inhibitors in synovium and cartilage.Regulation of matrix metalloproteinase genes by E2F transcription factors: Rb-Raf-1 interaction as a novel target for metastatic disease.Hes1 Increases the Invasion Ability of Colorectal Cancer Cells via the STAT3-MMP14 Pathway.Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitorsMembrane-type 4 matrix metalloproteinase (MT4-MMP) induces lung metastasis by alteration of primary breast tumour vascular architecture.Comparative Analysis of Matrix Metalloproteinase Family Members Reveals That MMP9 Predicts Survival and Response to Temozolomide in Patients with Primary Glioblastoma.SPARC upregulates MT1-MMP expression, MMP-2 activation, and the secretion and cleavage of galectin-3 in U87MG glioma cells.mRNA profiling of the cancer degradome in oesophago-gastric adenocarcinoma.Downregulation of membrane type-matrix metalloproteinases in the inflamed or injured central nervous system.Expression and prognostic impact of matrix metalloproteinase-2 (MMP-2) in astrocytomas.Caffeic Acid phenethyl ester inhibits oral cancer cell metastasis by regulating matrix metalloproteinase-2 and the mitogen-activated protein kinase pathway.The relationship between the expression of tumor matrix-metalloproteinase and the characteristics of magnetic resonance imaging of human gliomas.Pharmacoproteomics of a metalloproteinase hydroxamate inhibitor in breast cancer cells: dynamics of membrane type 1 matrix metalloproteinase-mediated membrane protein sheddingMT4-(MMP17) and MT6-MMP (MMP25), A unique set of membrane-anchored matrix metalloproteinases: properties and expression in cancerTumour-associated tenascin-C isoforms promote breast cancer cell invasion and growth by matrix metalloproteinase-dependent and independent mechanismsExpression and function of matrix metalloproteinase (MMP)-28TGF-[beta]1 limits plaque growth, stabilizes plaque structure, and prevents aortic dilation in apolipoprotein E-null mice.Expression of the matrix metalloproteases 2, 14, 24, and 25 and tissue inhibitor 3 as potential molecular markers in advanced human gastric cancer.New Strategies for the Next Generation of Matrix-Metalloproteinase Inhibitors: Selectively Targeting Membrane-Anchored MMPs with Therapeutic Antibodies.A complete compilation of matrix metalloproteinase expression in human malignant gliomas.Mycobacterium tuberculosis-infected human monocytes down-regulate microglial MMP-2 secretion in CNS tuberculosis via TNFα, NFκB, p38 and caspase 8 dependent pathways.
P2860
Q24617675-D9089EB1-45D4-496D-9A65-A1FB5998A0F5Q24683414-4148A8F0-98FF-4B2C-9FD2-1640FAE1CB2BQ24816674-BCC05CD0-CA32-4EFA-B0D6-CB3CB5D53260Q28394607-26D5EB7E-7F4B-47FE-B45C-D077563B1507Q33233386-61B4B711-26D5-4BAE-B49A-DDD6BA1C956CQ33359599-51C95BAF-B922-47B0-A914-B60CA678F61DQ33391513-D1D4A01A-E71F-42BD-BDED-4C7C9680F93DQ33743513-24B58A12-0F67-4D18-A7C5-7EFE73D68FE4Q33756272-E9C4A1C8-81B2-41A8-A7DF-6BCBC3E1E143Q33766886-7725FC84-1DF0-4CEE-8BB2-7A2B3D5317C2Q33771019-F820A651-37B3-409A-880C-10C8030ECAB0Q33828362-13F3AF0F-02C6-43F3-8BB6-9B616C8BC95AQ34058316-9F4F0C5F-1B26-4D03-A5C8-BFCD4A1BA36EQ34434205-F5119141-860E-47E3-A679-461355FC5174Q34627879-757B9E22-9748-4F44-ABB5-C333430D211CQ34768858-34C6D06C-6FF8-48D1-A83E-92D395E00A7DQ34978060-53FEE9A0-FA50-4EAE-A457-71C9DD3339E3Q35079243-2BA68B73-CC0D-473E-B47C-501394579C31Q35281840-EA6DE962-3A77-424D-B7C9-56466FEE3164Q35605620-23B3504C-507B-4E16-B38B-41914BAD493DQ35680985-7D5A52FD-D4B6-449F-A1D0-4FEA28BAF71BQ35864246-1FADD873-8792-4F84-84A9-C1CEE2EBFC6DQ35871254-9FA04C1A-6749-482C-AFC7-6C1BF883A120Q35893461-3D54DDFD-10FD-4380-969B-78DBBE690DCFQ35972486-EB90739B-7954-4079-9ABD-317D890A4F25Q35995952-BB9E1CEA-6D6D-40CE-81FE-D9C2F14A1F72Q36075298-082C5CC3-70F1-44E2-B54E-B28C81BC074AQ36138051-2A87C0EA-9F02-46D8-A773-A4770370E82CQ36289595-305605E9-A7D4-4A5A-93AA-0DBC4B200E0AQ36504702-C458B60D-CB74-425F-918D-A712D33B74CFQ36681415-662065E4-B617-4F87-BAB1-D1FEDD273BCBQ36804675-CC937C06-8E4D-4224-AE21-CD0531DF25E8Q37088968-4F456BFF-3003-4566-87FD-2A8000587C27Q37208797-5D442640-8965-4F04-A6BD-FB309CF45E8AQ37297945-B1FFC074-94FE-4693-9AE2-7B206B63094AQ37339703-4651694E-7CCB-469B-9A7A-4C91A07FBA41Q37616957-2A2D8076-4F6C-4C1E-86C6-3F5EF7A54BA4Q37820192-75C89EF1-DC35-42BA-915C-76593A0C249CQ38009800-117BE735-5C09-4749-8A96-1C36F01AB363Q39032038-B437CA00-CEF5-4D88-B66A-5708B54565EF
P2860
Elevated membrane-type matrix metalloproteinases in gliomas revealed by profiling proteases and inhibitors in human cancer cells.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Elevated membrane-type matrix ...... ibitors in human cancer cells.
@en
Elevated membrane-type matrix ...... ibitors in human cancer cells.
@nl
type
label
Elevated membrane-type matrix ...... ibitors in human cancer cells.
@en
Elevated membrane-type matrix ...... ibitors in human cancer cells.
@nl
prefLabel
Elevated membrane-type matrix ...... ibitors in human cancer cells.
@en
Elevated membrane-type matrix ...... ibitors in human cancer cells.
@nl
P2093
P1476
Elevated membrane-type matrix ...... hibitors in human cancer cells
@en
P2093
Alison Wheal
Caroline J Pennington
Dylan R Edwards
Jennifer Taplin
Peter A Forsyth
Robert K Nuttall
Voon Wee Yong
P304
P577
2003-03-01T00:00:00Z